| Literature DB >> 30181160 |
Yang Jiao1, Jiejie Zhao1,2, Zhijian Zhang3, Min Li1, Xi Yu1, Yanying Yang1, Jie Liu4, Shengjie Liao4, Duanzhuo Li4, Yuxing Wang4, Die Zhang4, Yulu Chen4, Guojun Shi5, Bin Liu6,4, Yan Lu6, Xiaoying Li6.
Abstract
Obesity is usually associated with an increased risk of nonalcoholic fatty liver disease that is characterized by accumulation of excessive triglyceride (TG) in hepatocytes. However, the factors involved in the obesity-induced hepatosteatosis are poorly defined. Here, we report that SRY-box containing gene 4 (Sox4), a transcription factor that regulates cell proliferation and differentiation, plays an important role in hepatic TG metabolism. Sox4 expression levels are markedly upregulated in livers of obese rodents and humans. Adenovirus-medicated overexpression of Sox4 in the livers of lean mice promotes liver steatosis, whereas liver-specific knockdown of Sox4 ameliorates TG accumulation and improves insulin resistance in obese mice. At the molecular level, we show that Sox4 could directly control the transcription of SREBP-1c gene through binding to its proximal promoter region. Thus, we have identified Sox4 as an important component of hepatic TG metabolism.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30181160 DOI: 10.2337/db18-0184
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.461